GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Therapeutics Co Ltd (XKRX:115450) » Definitions » 5-Year Yield-on-Cost %

HLB Therapeutics Co (XKRX:115450) 5-Year Yield-on-Cost % : 0.00 (As of May. 26, 2024)


View and export this data going back to 2010. Start your Free Trial

What is HLB Therapeutics Co 5-Year Yield-on-Cost %?

HLB Therapeutics Co's yield on cost for the quarter that ended in Mar. 2024 was 0.00.


The historical rank and industry rank for HLB Therapeutics Co's 5-Year Yield-on-Cost % or its related term are showing as below:



XKRX:115450's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.8
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of HLB Therapeutics Co's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, HLB Therapeutics Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Therapeutics Co's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Therapeutics Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where HLB Therapeutics Co's 5-Year Yield-on-Cost % falls into.



HLB Therapeutics Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of HLB Therapeutics Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

HLB Therapeutics Co  (XKRX:115450) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


HLB Therapeutics Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of HLB Therapeutics Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Therapeutics Co (XKRX:115450) Business Description

Traded in Other Exchanges
N/A
Address
22F, Parkview Tower, 6, Jeongja-Dong, Bundang-Gu, Seongnam-si, 463-863, KOR, 463-811
HLB Therapeutics Co Ltd is a bio company that pursues first-in-class and innovates new drug development. With the development and validation of new drugs for various hard-to-treat disorders, HLB Therapeutics is becoming a global biopharmaceutical company focused on alleviating patient suffering.

HLB Therapeutics Co (XKRX:115450) Headlines

No Headlines